share_log

Altimmune | 4: Statement of changes in beneficial ownership of securities-Officer Roberts M Scot

Altimmune | 4: Statement of changes in beneficial ownership of securities-Officer Roberts M Scot

Altimmune | 4：持股變動聲明-高管 Roberts M Scot
美股sec公告 ·  08/02 05:46
牛牛AI助理已提取核心訊息
On July 31, 2024, Altimmune, Inc.'s Chief Scientific Officer, M Scot Roberts, completed a purchase of 650 shares of common stock at a price of $5.41 per share. Following this transaction, Roberts directly holds a total of 43,310 shares in the company. Additionally, it was disclosed that Roberts has an indirect ownership of 15 shares held by his spouse. The transaction, which is part of the direct holdings of non-derivative securities, reflects a vested interest in the company's performance by one of its key executives.
On July 31, 2024, Altimmune, Inc.'s Chief Scientific Officer, M Scot Roberts, completed a purchase of 650 shares of common stock at a price of $5.41 per share. Following this transaction, Roberts directly holds a total of 43,310 shares in the company. Additionally, it was disclosed that Roberts has an indirect ownership of 15 shares held by his spouse. The transaction, which is part of the direct holdings of non-derivative securities, reflects a vested interest in the company's performance by one of its key executives.
2024年7月31日，Altimmune公司的首席科學官萬•斯科特•羅伯茨以每股5.41美元的價格購買了650股普通股。此次交易後，羅伯茨直接持有公司的43310股股份。此外，披露了羅伯茨的配偶持有的15股間接所有權。這項交易是非衍生證券的直接持股的一部分，反映了該公司的一個關鍵高管對公司業績的既得利益。
2024年7月31日，Altimmune公司的首席科學官萬•斯科特•羅伯茨以每股5.41美元的價格購買了650股普通股。此次交易後，羅伯茨直接持有公司的43310股股份。此外，披露了羅伯茨的配偶持有的15股間接所有權。這項交易是非衍生證券的直接持股的一部分，反映了該公司的一個關鍵高管對公司業績的既得利益。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。